1,4-bis(3,4-dimethylphenyl)-3-[4-(propan-2-yl)phenyl]piperazine-2,5-dione

Dear Customer,

We are working. Read MolPort blog with latest update on Covid-19 effect on compound sourcing, our suppliers, logistics, services & answers on FAQ.

MolPort Team


Compound number:
MolPort-039-070-470
IUPAC:
1,4-bis(3,4-dimethylphenyl)-3-[4-(propan-2-yl)phenyl]piperazine-2,5-dione
IUPAC traditional:
1,4-bis(3,4-dimethylphenyl)-3-(4-isopropylphenyl)piperazine-2,5-dione
SMILES:
CC(C)c1ccc(cc1)C1N(C(=O)CN(C1=O)c1ccc(C)c(C)c1)c1ccc(C)c(C)c1
InChI key:
BRDPRBXNULLIIG-UHFFFAOYSA-N
Molecular formula:
C29H32N2O2
Molecular weight: 440.587
Solubility: not available

Marketplace Offers

S&H to USA: 50.00 USD
S&H to World: 50.00 USD

Supplier Catalogue Data


Catalog: Screening compound Ships out: 12 business days Purity: n/a
Last updated: today In warehouse: 179.70 mg
Pack size Ships out Price Qty
5 mg July 21, 2020 42.48 USD
ADD TO CART
10 mg July 21, 2020 63.72 USD
ADD TO CART
50 mg July 21, 2020 160.48 USD
ADD TO CART

More Information

Compound Identifiers
Compound number: MolPort-039-070-470

Names, Synonyms and 3rd Party Identifiers

InChI
InChI: 1S/C29H32N2O2/c1-18(2)23-9-11-24(12-10-23)28-29(33)30(25-13-7-19(3)21(5)15-25)17-27(32)31(28)26-14-8-20(4)22(6)16-26/h7-16,18,28H,17H2,1-6H3
InChI key: BRDPRBXNULLIIG-UHFFFAOYSA-N

Calculated Properties
Molecular formula: C29H32N2O2
Molecular weight: 440.587

Other

Sales contact

+1 215 717 7447

+371 67790398

sales@molport.com


Our customer services department will be happy to help you Monday to Friday 7 a.m. to 9 p.m. GMT (2 a.m. - 4 p.m. EST).


2020 MolPort, v3.74, release date 30-06-2020 10:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.